3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Status
Recruiting
2
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Endocrine
2
CNS
2
Conditions
Prostatic Neoplasms
7
Brain Neoplasms
7
Squamous Cell Carcinoma of Head and Neck
4
Sarcoma
4
Carcinoma, Non-Small-Cell Lung
4
Solid Tumor, Adult
3
Rhabdomyosarcoma
3
Neoplasms
3
Meningioma
3
Glioma
3
Esophageal Neoplasms
3
Pituitary Neoplasms
2
Osteosarcoma
2
Nerve Sheath Neoplasms
2
Glioblastoma
2
Craniopharyngioma
2
Chordoma
2
Chondrosarcoma
2
Breast Neoplasms
2
Bone Neoplasms
2
Wilms Tumor
1
Vascular Neoplasms
1
Stage I Prostate Adenocarcinoma AJCC v7
1
Solitary Fibrous Tumors
1
Solid Tumor
1
Smooth Muscle Tumor
1
Sarcoma, Ewing
1
Sarcoma, Clear Cell
1
Resectable Lung Non-Small Cell Carcinoma
1
Recurrent Head and Neck Carcinoma
1
Interventions
Proton Therapy
2
Surgical Procedures, Operative
1
Radiation Dose Hypofractionation
1
Protons
1
Nivolumab
1
Neurosurgical Procedures
1
Ipilimumab
1
Dosage Forms
1
Deamino Arginine Vasopressin
1
Clinical Laboratory Techniques
1
Cabergoline
1
Blood Specimen Collection
1
2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Pituitary Neoplasms
×
Proton Therapy
×
1 year
×
Clear all
NCT04278118
2026-02-17
HiPPI
Emory University
Phase NA
Recruiting
70 enrolled
NCT06831461
2025-09-16
PRIDE
Tata Memorial Centre
Phase NA
Recruiting
156 enrolled